Page 72 - Consumer Tissue News Today

Should You Buy or Sell Kimberly-Clark Stock? Get The Latest KMB Stock Forecast, Price Target, Dividend Info, Headlines, Short Interest at MarketBeat.

/PRNewswire/ -- Essity continuously evaluates the product portfolios within the companys three business areas, Health & Medical, Consumer Goods and...

Heritage Investment Group Inc. bought a new position in shares of Kimberly-Clark Co. (NYSE:KMB – Get Rating) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,495 shares of the company’s stock, valued at approximately $203,000. A number of […]

STOCKHOLM : Hygiene products group Essity said on Wednesday it has initiated a strategic review of its stake in China-based Vinda and its Consumer Tissue Private Label Europe business.The Swedish company said in a statement the aim of the review is to reduce its Consumer Tissue division's share of group

Kimberly-Clark (NYSE:KMB – Get Rating) had its target price lifted by investment analysts at Royal Bank of Canada from $118.00 to $125.00 in a note issued to investors on Wednesday, The Fly reports. Royal Bank of Canada’s price target would indicate a potential downside of 13.66% from the company’s previous close. Several other equities research […]

Kimberly-Clark (NYSE:KMB – Get Rating) had its price target upped by research analysts at Berenberg Bank from $132.00 to $144.00 in a report released on Wednesday, The Fly reports. Berenberg Bank’s price objective would indicate a potential downside of 0.46% from the company’s previous close. KMB has been the topic of several other reports. StockNews.com […]

Hamel Associates Inc. grew its position in Kimberly-Clark Co. (NYSE:KMB – Get Rating) by 141.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,778 shares of the company’s stock after acquiring an additional 8,075 shares during the period. Hamel Associates […]

HM Payson & Co. cut its holdings in Kimberly-Clark Co. (NYSE:KMB – Get Rating) by 0.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,164 shares of the company’s stock after selling 125 shares during the period. HM Payson & Co.’s […]

Should You Buy or Sell Kimberly-Clark Stock? Get The Latest KMB Stock Forecast, Price Target, Dividend Info, Headlines, Short Interest at MarketBeat.

Meridian Investment Counsel Inc. lowered its holdings in shares of Kimberly-Clark Co. (NYSE:KMB – Get Rating) by 3.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,164 shares of the company’s stock after selling 250 shares during the period. […]